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Summary
In addition to controlling a switch to glycolytic me-
tabolism and induction of erythropoiesis and angio-
genesis, hypoxia promotes the undifferentiated cell
state in various stem and precursor cell populations.
Here, we show that the latter process requires Notch
signaling. Hypoxia blocks neuronal and myogenic dif-
ferentiation in a Notch-dependent manner. Hypoxia
activates Notch-responsive promoters and increases
expression of Notch direct downstream genes. The
Notch intracellular domain interacts with HIF-1, a
global regulator of oxygen homeostasis, and HIF-1
is recruited to Notch-responsive promoters upon
Notch activation under hypoxic conditions. Taken to-
gether, these data provide molecular insights into
how reduced oxygen levels control the cellular differ-
entiation status and demonstrate a role for Notch in
this process.
Introduction
It is critical for multicellular organisms to maintain
oxygen homeostasis, and complex mechanisms have
evolved to sense oxygen levels and convert this infor-
mation into appropriate physiological responses (Bru-
ick, 2003). Hypoxia leads to a change in the energy me-
tabolism that shifts from oxidative phosphorylation to
glycolysis. In addition, induction of angiogenesis serves
to increase vascular density in an area of localized hyp-
oxia within a tissue, and, in response to systemic hyp-
oxia, erythropoiesis is induced. Hypoxia is also a patho-
physiological component of many disorders, including
ischemic diseases and cancer (Semenza, 2001).
Cells have developed a molecular signaling mecha-
nism for oxygen sensing. An important mediator is the
transcription factor HIF-1α, which is hydroxylated at
specific proline residues by prolyl hydroxylases that act
as oxygen sensors (Bruick and McKnight, 2001; Epstein
et al., 2001). At normoxia, hydroxylation of HIF-1α (Ivan
et al., 2001; Jaakkola et al., 2001) leads to decreased
stability of HIF-1α through rapid ubiquitylation and deg-
radation by the 26S proteasome. HIF-1α is ubiqui-
tylated by the E3 ubiquitin ligase pVHL (von Hippel-Lin-*Correspondence: urban.lendahl@cmb.ki.se
1Present address: Department of Biosciences at Novum, Karolin-
ska Institutet, SE-141 57 Huddinge, Sweden.dau tumor suppressor protein) (Cockman et al., 2000;
Ohh et al., 2000; Tanimoto et al., 2000). Under hypoxic
conditions, HIF-1α levels are elevated as a result of re-
duced ubiquitylation and decreased proteasome-medi-
ated degradation. Stabilized HIF-1α binds, in conjunc-
tion with HIF-1β (also referred to as ARNT), to specific
hypoxia response elements (HREs) present in the pro-
moters and enhancers of several effector genes. Among
the known HIF-1α target genes are genes important for
angiogenesis, erythropoiesis, and glucose metabolism,
such as vascular endothelial growth factor (VEGF), ery-
thropoietin, and phosphoglycerate kinase 1 (PGK1), re-
spectively (reviewed by Semenza, 2001; Bruick, 2003).
In addition to altering cellular energy metabolism and
angiogenesis, hypoxia influences proliferation and dif-
ferentiation of various stem/progenitor cell populations.
This was originally described in neural crest (Morrison
et al., 2000) and CNS stem cells (Studer et al., 2000).
Culturing of neural crest stem cells at 5% O2 results
in increased proliferation and the formation of more
multipotent clones as compared to culturing at 20% O2
(Morrison et al., 2000). Experimental differentiation of
neural crest stem cells under hypoxic conditions allows
the cells to differentiate into the sympathoadrenal lin-
eage, a lineage choice not observed in normoxia (Mor-
rison et al., 2000). For CNS precursor cells, culturing at
reduced oxygen levels results in increased proliferation
and reduced cell death, yielding an increased number
of precursor cells. Likewise, differentiation toward the
dopaminergic fate was increased (Studer et al., 2000).
In addition, hypoxia leads to inhibition of adipocyte dif-
ferentiation (Yun et al., 2002). As a consequence of
these findings, hypoxia is now routinely included in sev-
eral stem cell culturing protocols to improve yields of
stem cells (Rajan et al., 2003). Collectively, these data
from different cell types suggest the existence of a
more general link between hypoxia and maintenance of
the undifferentiated cell state, but little is known about
the cellular signaling mechanisms underpinning this
process.
Notch signaling is an attractive candidate for this
process, as it often functions to maintain the stem/pro-
genitor cell state, for example in myogenesis (Nofziger
et al., 1999; Dahlqvist et al., 2003) and hematopoiesis
(Varnum-Finney et al., 2000). Notch signaling is evolu-
tionarily highly conserved and critical for controlling
cell fate choices in most metazoan species (Artavanis-
Tsakonas et al., 1999; Hansson et al., 2004). The Notch
receptor undergoes a complex series of at least three
different proteolytic cleavages. Activation by DSL (Delta,
Serrate, and Lag-2) ligands presented on neighboring
cells eventually leads to the liberation of the Notch in-
tracellular domain (Notch ICD), which translocates to
the nucleus and interacts with the DNA binding protein
CSL (also referred to as RBP-Jk and CBF-1 in mam-
mals, and Suppressor of Hairless [Su(H)] in Drosophila).
This leads to activation of Hes and Hey genes (the latter
is also known as Herp, Hesr, HRT, CHF, and gridlock),
which, in turn, reduces expression or blocks the func-
tion of downstream transcriptional effectors like Neuro-
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618Figure 1. Hypoxia-Induced Inhibition of Myogenic and Neuronal Differentiation Requires Functional Notch Signaling
(A) Differentiated (MHC-positive) C2C12 cells at normoxia or hypoxia in the presence or absence of γ-secretase inhibitor (L-685,458).
(B) Quantification of the percentage of MHC-positive C2C12 cells, relative to DAPI-stained nuclei. “**” indicates significant at p < 0.01, and
“^” indicates not significant at p > 0.05 by Student’s t test. The bars represent the mean ± SE of three independent experiments performed
in duplicate.
(C) Differentiated (MHC-positive) satellite cells at normoxia or hypoxia in the presence or absence of γ-secretase inhibitor (L-685,458).
(D) Quantification of the percentage of MHC-positive satellite cells, relative to DAPI-stained nuclei.
(E) Differentiated (Tuj-1-positive) neural stem cells (nsc) treated with hypoxia or kept at normoxia in the presence or absence of γ-secretase
inhibitor (L-685,458).
(F) Quantification of the percentage of Tuj-1-positive neural stem cells, relative to DAPI-stained nuclei.
(G) Proliferative index of neural stem cells (phospho-histone-3 positive) treated with hypoxia or kept at normoxia in the presence or absence
of the γ-secretase inhibitor L-685,458.
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619substantial increase in the proportion of neuronally dif-
(H) Apototic index of neural stem cells at normoxia or hypoxia in the presence or absence of the γ-secretase inhibitor (L-685,458).
(I) Quantitative RT-PCR of Hey-2 mRNA after 4 hr of hypoxia treatment of C2C12 cells.
(J) Quantitative RT-PCR of Hes-1 mRNA after 4 hr of hypoxia treatment of neural stem cells. Values are significant at **p < 0.01 and *p < 0.05,
as indicated in the figure. Bars represent Hey or Hes mRNA expression relative to expression of b-actin.
Data shown represent the mean ± SE of three independent experiments performed in triplicate.
This promoter, 12XCSL-luc, is composed of six multi-genin (Cornell and Eisen, 2002), Mash (de la Pompa et
al., 1997), and MyoD (Kopan et al., 1994).
In this report, we asked if Notch signaling plays a role
in how hypoxia maintains cells in a more undifferenti-
ated state. We show that hypoxia blocks differentiation
of neuronal and myogenic progenitors and that this re-
quires functional Notch signaling. Hypoxia leads to re-
cruitment of HIF-1α to a Notch-responsive promoter
and elevated expression of Notch downstream genes.
Results
Hypoxia Inhibits Differentiation in the Myogenic
Cell Line C2C12, in Satellite Cells,
and in Neural Stem Cells
To test whether hypoxia inhibits differentiation in a cell
system that depends on Notch signaling to block differ-
entiation, we first analyzed the myogenic C2C12 cell
line. C2C12 cells can be induced to fuse and form myo-
tubes expressing myosin heavy chain (MHC) protein
(Soukup et al., 1995), a marker for terminally differenti-
ated myocytes. This process is regulated by Notch, as
coculturing with ligand-expressing cells or introduction
of the Notch ICD blocks differentiation (Kopan et al.,
1994; Kuroda et al., 1999). Culturing of C2C12 cells at
hypoxia (1% O2) for 4 days resulted in a 4-fold decrease
in the number of differentiated cells (32% and 8%
MHC-positive cells at normoxia and hypoxia, respec-
tively) (Figures 1A and 1B). To establish whether the
inhibition of differentiation was linked to Notch signal-
ing, C2C12 cells were simultaneously treated with hyp-
oxia and a γ-secretase inhibitor (L-685,458), which pre-
vents Notch cleavage and thus the release of Notch
ICD from the membrane (Dahlqvist et al., 2003). L-685,458
treatment resulted in a substantial abrogation of the
hypoxia-induced inhibition of differentiation, as 25% of
the cells were MHC positive (Figures 1A and 1B). This
suggests that the hypoxia-induced inhibition of C2C12
differentiation is to a considerable extent dependent on
functional Notch signaling. To address whether this
Notch dependency is also observed in primary myo-
genic cells, we tested the same combination of hypoxia
and L-685,458 in satellite cells. Reduced differentiation
was observed at hypoxia, and differentiation was sub-
stantially restored in the presence of L-685,458 (Figures
1C and 1D).
To study whether hypoxia and Notch signaling are
also linked in other stem/precursor cell types, we ana-
lyzed primary neural stem cells, derived from embry-
onic rat cortex (Johe et al., 1996; Hermanson et al.,
2002). These cells are maintained as neural precursor
cells by the presence of fibroblast growth factor-2
(FGF-2) in the culture medium, and they begin to dif-
ferentiate when FGF-2 is withdrawn (Johe et al., 1996).
In keeping with previous reports (Johe et al., 1996), aferentiating, i.e., Tuj-1-expressing cells, was observed
at 48 hr after FGF-2 withdrawal (22%; Figures 1E and
1F), as compared to 6% when FGF-2 was supple-
mented to the medium (data not shown). Culture of the
cells under hypoxic conditions for 48 hr after FGF-2
withdrawal resulted in a decrease in the number of Tuj-
1-positive cells from 22% to 14% (Figures 1E and 1F).
The addition of L-685,458 during the 48 hr period com-
pletely rescued the inhibitory effect on neuronal differ-
entiation exerted by hypoxia, as 24% of the cells now
were Tuj-1 positive (Figures 1E and 1F). The reduction
in Tuj-1-positive cells in hypoxia was accompanied by
an increase in the number of proliferating cells and
a decrease in apoptotic cells (Figures 1G and 1H),
whereas the proportion of GFAP-expressing cells was
not significantly altered (Figure S1; see the Supplemen-
tal Data available with this article online). Taken to-
gether, these data establish that the hypoxia-induced
effect on blocking neuronal and myogenic differentia-
tion requires functional Notch signaling.
Hypoxia Increases Expression of Notch Downstream
Genes in a Notch-Dependent Manner
As the experiments described above implicated Notch
signaling in mediating the effect of hypoxia on differen-
tiation, we next wanted to investigate whether expres-
sion of Notch immediate downstream genes (Hes and
Hey) (Greenwald, 1998; Mumm and Kopan, 2000) was
altered by hypoxia. We therefore analyzed by real-time
PCR Hes and Hey mRNA levels in C2C12 and neural
stem cells. In C2C12 cells, Hes-1 mRNA levels were
not altered by hypoxia (data not shown), whereas Hey-2
mRNA levels were increased 12-fold after 4 hr of hyp-
oxia treatment (Figure 1I). In neural stem cells, Hes-1
expression was increased 1.8-fold after 4 hr of hypoxic
treatment when compared to cells grown in normoxia
(Figure 1J).
To study the relationship between hypoxia and Notch
signaling in more detail, we analyzed the hypoxic re-
sponse in the embryonic carcinoma cell line P19 (Mc-
Burney, 1993), which can undergo neuronal differentia-
tion controlled by Notch signaling (Nye et al., 1994).
Hypoxia resulted in 4-fold elevated Hes-1 mRNA ex-
pression in P19 cells (Figure 2A). We next analyzed
whether the observed increase in Hes-1 mRNA levels
was a result of transcriptional activation. A Hes-1 repor-
ter construct composed of 0.3 kb of the Hes-1 pro-
moter linked to the luciferase gene (Hes-1-luc) (Jarriault
et al., 1995) was transfected into P19 cells. Hypoxia
markedly increased expression of the reporter gene,
and this increase was largely reduced by L-685,458
(Figure 2B), which suggests that cleavage of the Notch
receptor is required. An alternative way to measure
Notch-mediated transcriptional activation is to use a
synthetic, highly Notch-specific promoter construct.
Developmental Cell
620Figure 2. Hypoxia Increases Notch Signaling in P19 Cells
(A) Quantitative RT-PCR of Hes-1 mRNA in P19 cells cultured at hypoxia for 4 hr. Values are presented as Hes-1 mRNA expression relative to
expression of b-actin. Bars represent the mean ± SE of three independent experiments performed in triplicate.
(B) Activation of Hes-1-luc in P19 cells treated with hypoxia for 12 hr or kept at normoxia in the presence or absence of γ-secretase inhibitor
for 15 hr.
(C) Activation of 12XCSL-luc after treatment by normoxia, hypoxia, CoCl2 (100 M), or 2,2#-dipyridyl (100 M) for 12 hr in the presence or
absence of γ-secretase inhibitor for 15 hr.
(D) Hes-1-luc activation after expression of Notch 1 ICD in P19 cells grown at normoxia or hypoxia for 14 hr.
(E) Hes-1-luc activation after Notch 1 ICD expression after treatment with CoCl2 (100 M), 2,2#-dipyridyl (100 M), or FeCl2 (100 M) for 14 hr.
(F) Activation of Hes-1-luc by Notch 1 ICD expression in P19 cells grown in normoxia in the presence or absence of ciclopirox olamine (5 M)
for 14 hr.
(G) Activation of 12XCSL-luc by Notch 1 ICD during normoxia in the presence or absence of ciclopirox olamine (5 M). The graphs represent
fold activation relative to β-galactosidase expression. Values are significant at **p < 0.01 or *p < 0.05, as indicated in the figure.
The bars represent the mean ± SE of two independent experiments performed in triplicate.merized dimeric CSL binding sites and, thus, responds
only to Notch ICD-CSL-mediated activation (Kato et al.,
1997). Expression of 12XCSL-luc was induced by hyp-
oxia (3.9-fold), and this activation was completely
blocked by the addition of L-685,458 (Figure 2C). Stabi-
lization and activation of HIF-1α can be induced in nor-
moxia by agents, which function by chelating iron ions,
such as 2,2#-dipyridyl or ciclopirox olamine, or by com-
pounds that substitute ferrous iron with transition cat-
ions such as Co2+ or Ni2+ (Wanner et al., 2000; Linden
et al., 2003). All of these compounds induce HIF-1α
function by inhibiting prolyl and asparaginyl hydrox-
ylase activities involved in HIF-α regulation (Bruick and
McKnight, 2001; Epstein et al., 2001; Lando et al.,
2002a). The effects on Notch signaling of CoCl2 and
2,2#-dipyridyl were tested, and a 2- to 3-fold activation
of 12XCSL-luc was observed (Figure 2C). In sum, these
data suggest that hypoxia enhances endogenous
Notch signaling, which results in increased activation
of transcription of Notch downstream genes.
Hypoxia Increases the Activity of Notch 1 ICD
The activation of a Notch response by hypoxia could
conceivably involve a number of levels in the Notch sig-
naling system. The γ-secretase inhibitor experiments
described above suggest that liberation of Notch ICD
is required for the hypoxic response. Transfection of a
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INotch 1 ICD expression plasmid activated the Hes-1-uc reporter gene 10-fold in normoxia, consistent with
revious reports (Beatus et al., 2001; Blokzijl et al.,
003). This activation was elevated to 27-fold under
ypoxic conditions (Figure 2D). When Notch 1 ICD-
xpressing cells were exposed to CoCl2 or 2,2#-dipyri-
yl, Hes-1-luc expression increased to levels similar to
hose observed in hypoxia-treated cells (approximately
0-fold) (Figure 2E). Moreover, exposure of transfected
ells to ciclopirox olamine resulted in elevated expres-
ion of both the Hes-1-luc and 12XCSL-luc reporters
Figures 2F and 2G). In the converse experiment, eleva-
ion of Fe2+ levels by addition of FeCl2 resulted in re-
uced Hes-1-luc expression, both in cells with endoge-
ous Notch signaling as well as in cells transfected with
otch 1 ICD (Figure 2E). The addition of FeCl2 has pre-
iously been shown to enhance prolyl 4-hydroxylase
ctivity, to enhance interaction of HIF-1α with pVHL,
nd, subsequently, to promote degradation of HIF-1α
Ivan et al., 2001; Jaakkola et al., 2001). Taken together,
hese data demonstrate that hypoxia and hypoxia-mim-
cking agents known to regulate HIF function affected
ignaling mediated by the Notch intracellular domain.
ypoxia Stabilizes the Notch 1 ICD
o test whether the stability of Notch ICD was altered
y hypoxia, we measured the protein levels of Notch 1
CD in P19 cells under normoxic and hypoxic condi-
tions in a pulse-chase experiment. To more closely re-
Crosstalk between Hypoxia and Notch
621Figure 3. Hypoxia or Ectopically Expressed HIF-1α Elevates Notch
1 ICD Protein Levels and Increases the Notch Downstream Re-
sponse
(A) Notch 1 DE was transfected into P19 cells and labeled in a
pulse-chase experiment with 35S-methionine. The cells were grown
at hypoxia or normoxia and harvested after a chase of indicated
length. Notch 1 ICD was immunoprecipitated and analyzed by
SDS-PAGE, followed by autoradiography.
(B) Endogenous expression of HIF-1α in P19 cells grown at nor-
moxia or hypoxia or in the presence of 2,2#-dipyridyl (100 M) or
CoCl2 (100 M) for 8 hr. HIF-1α was immunoprecipitated, separated
by SDS-PAGE, and detected by Western blot by using an anti-HIF-
1α antibody.
(C) Western blot analysis of Myc-Notch ICD protein levels in COS-7
cells at normoxia or hypoxia after expression of Myc-Notch 1 ICD
alone or after coexpression with HIF-1α or HIF-1α(1–390).Notch 1 ICD and pVHL was observed, whereas, as ex-
(D) Quantitative RT-PCR of Hey-2 mRNA after 6 hr of hypoxia treat-
ment of wild-type (+/+) or HIF-1α-deficient (−/−) mEF cells. Values
are significant at **p < 0.01 and are not significant at ^p > 0.05,
as indicated in the figure. Bars represent Hey-2 mRNA expression
relative to expression of b-actin. Data shown represent the mean ±
SE of two independent experiments performed in triplicate.
(E) RT-PCR of PGK1 mRNA in HIF-1α (+/+) and (−/−) mEF cells cul-
tured at normoxia or hypoxia for 6 hr.semble the in vivo situation, we studied the stability of
a Notch ICD generated from a membrane-tethered form
of Notch via S3 cleavage, Notch 1 E (Kopan et al.,
1996). Notch 1 E, which mimics an S2-cleaved recep-
tor, rapidly undergoes S3 processing in the cells, thus
generating Notch 1 ICD. Transfection of Notch 1 DE
was followed by a 4 hr pulse with 35S-methionine and
was chased for 0, 2, 4, 6, and 8 hr under normoxic or
hypoxic conditions. Immunoprecipitated Notch 1 ICD
showed an increased half-life in hypoxia-treated cells.
By 4 hr, approximately 1.8-fold higher Notch protein
levels were observed in hypoxia compared to nor-
moxia, a difference that was further elevated to 2.3-fold
after 6 hr of chase (Figure 3A). At normoxia, low levels
of endogenous HIF-1α were observed. These were sub-
stantially increased by 8 hr of treatment with hypoxia,
2,2#-dipyridyl, or CoCl2 (Figure 3B).
We next explored whether there was a link between
increased amounts of Notch ICD during hypoxia and
HIF-1α or pVHL. First, we transfected COS-7 cells with
Notch 1 ICD together with VHL or Sel-10, since Sel-10
(cdc4) is a known negative regulator of Notch ICD pro-
tein levels (Oberg et al., 2001). Western blot analysis
revealed that Sel-10, as expected, reduced the amounts
of Notch 1 ICD, while no reduction was observed after
the addition of pVHL (data not shown). When Notch 1
ICD was transfected together with HIF-1a or a tran-
scriptionally inactive mutant of HIF-1α, HIF-1a(1–390),
stabilization of Notch 1 ICD was observed, both in nor-
moxia and, more strikingly, in hypoxia (Figure 3C). Col-
lectively, these data show that hypoxia increases the
stability of Notch ICD, and they indicate a role for HIF-
1α in this process. To directly investigate whether HIF-
1α is required for the increased Notch activity during
hypoxia, we compared the hypoxia-mediated response
on Hey-2 mRNA levels in mouse embryonic fibroblast
cells (mEFs) genetically engineered to lack HIF-1α
(Goda et al., 2003). Hey-2 mRNA levels were robustly
increased in wild-type mEFs after 6 hr at hypoxia, while
no significant increase was observed in the HIF-1α−/−
mEFs (Figure 3D). As expected, PGK1 mRNA levels
were increased during hypoxia only in the wild-type,
but not in the HIF-1α−/− mEFs cells (Figure 3E).
Notch 1 ICD Interacts with HIF-1,
but Not with pVHL
In light of the Notch 1 ICD stabilization data, we exam-
ined whether Notch ICD physically interacts with HIF-
1α or pVHL. Immunoprecipitation of FLAG-HIF-1α re-
vealed an interaction with 35S-labeled Notch 1 ICD,
and, conversely, immunoprecipitation of Myc-Notch 1
ICD demonstrated an interaction with 35S-labeled HIF-
1α (Figure 4A). In contrast, no interaction between
Developmental Cell
622Figure 4. Notch Interacts with HIF-1α, but Not with pVHL
(A) In vitro-translated FLAG-HIF-1α and 35S-Myc-Notch 1 ICD was immunoprecipitated with anti-FLAG (left panel) or FLAG-35S-HIF-1α, and
Myc-Notch 1 ICD was immunoprecipitated with anti-Myc (right panel) and subjected to SDS-PAGE and autoradiography.
(B) In vitro-translated 35S-pVHL, FLAG-HIF-1α, and Myc-Notch 1 ICD were immunoprecipitated with anti-Myc or anti-FLAG, as indicated and
analyzed by SDS-PAGE and autoradiography.
(C) Schematic representation of the several FLAG-tagged HIF-1α mutants used to map the interaction domain (left). 35S-Notch ICD and
different FLAG-tagged HIF-1α mutants (as indicated) were immunoprecipitated with anti-FLAG (right panel) and subjected to SDS-PAGE
and autoradiography.
(D) Relative luciferase activity after cotransfection of 12XCSL-luc with Notch 1 ICD and HIF-1a into P19 cells grown at normoxia and hypoxia
for 16 hr.
(E) A transactivation dead HIF-1α, HIF-1α(1–390), does not enhance Notch ICD-induced activation of 12XCSL-luc at normoxia, whereas wild-
type HIF-1α does.
(F) HIF-1α, but neither HIF-1α(1–390) nor Notch 1 ICD, significantly activates transcription of the hypoxia response element (HRE-luc) in
P19 cells.
(G) Hypoxia significantly increases the HIF transactivation potential of the HRE-luc reporter gene after cotransfection into A-498 VHL-defi-
cient cells.
(H) Relative luciferase activity after cotransfection of Hes1-luc and Notch 1 ICD in A-498 cells grown at normoxia or hypoxia for 16 hr.
(I) Relative luciferase activity after cotransfection of 12XCSL-luc with Notch 1 ICD in VHL-deficient cells grown at normoxia or hypoxia for 16
hr. Values are presented as fold activation of luciferase expression relative to β-galactosidase expression.
Values are significant at **p < 0.01, *p < 0.05, and “p < 0.06, as indicated in the figure. The bars represent the mean ± SE of two independent
experiments performed in triplicate.
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623pected (Cockman et al., 2000; Ohh et al., 2000; Tani-
moto et al., 2000), HIF-1α and pVHL interacted (Figure
4B). pVHL did not significantly increase the level of
ubiquitylation of Notch 1 ICD, while Sel-10 markedly
elevated Notch 1 ICD ubiquitylation (data not shown),
in agreement with previous reports (Oberg et al., 2001).
Taken together, these observations suggest that the
primary link between hypoxia and Notch signaling in-
volves an interaction between Notch ICD and HIF-1α,
but not a direct interaction between Notch ICD and
pVHL. To find out which domain(s) in HIF-1α is respon-
sible for the observed interaction, we generated a set of
truncated FLAG-tagged HIF-1α constructs and tested
their potential to interact with Notch 1 ICD. In Figure
4C, we show that a HIF-1α protein lacking only the
N-terminal transactivation domain (N-TAD) and the trun-
cated proteins HIF-1α(1–584), HIF-1α(392–531), and
HIF-1α(392–622) (Figure 4C; left panel) interacted with
Notch 1 ICD, as did a form of HIF-1α containing amino
acid residues 1–390 linked to 629–822, i.e., lacking resi-
dues 391–628 (Figure 4C; right panel). In contrast, the
N-terminally truncated HIF-1α(531–822) showed no in-
teraction with Notch 1 ICD. These data indicate that
there is an interaction domain in the N-terminal portion
of HIF-1α spanning amino acid residues 1–390, and a
second domain in the region corresponding to amino
acid residues 390–531. The C-terminal region of HIF-
1α, from amino acid residue 531 to the C terminus,
which is required for transactivation (Ruas et al., 2002;
Carrero et al., 2000), appears to be dispensable for in-
teraction with Notch 1 ICD.
The C-Terminal Transactivation Domain of HIF-1 Is
Required for Increased Notch Signaling
The protein interaction data suggest a role for HIF-1α
in the stabilization of Notch ICD and increase in Notch
signaling. Transfection of HIF-1a together with Notch
1 ICD into P19 cells resulted in elevated levels of
12XCSL-luc expression, both at normoxia and hypoxia
(Figure 4D). In contrast, cotransfection of Notch 1 ICD
together with HIF-1a(1–390) did not activate 12XCSL-
luc (Figure 4E), and similar data were obtained for the
other HIF-1α mutants that interacted with Notch, i.e.,
HIF-1α(1–584) and HIF-1α(392–531) (data not shown).
As a control, wild-type HIF-1α, but not HIF-1α(1–390),
was shown to activate an HRE-luc construct (Figure
4F). Conversely, transfected Notch ICD had no detecta-
ble effect on HRE-luc activation (Figure 4F). In conclu-
sion, these data show that although the HIF-1α inter-
action interface with Notch 1 ICD is located in the
N-terminal region of HIF-1α, hypoxia-dependent en-
hancement of Notch signaling requires the C-terminal
region of HIF-1α.
Next, we investigated the Notch response to hypoxia
in the pVHL-deficient cell line A-498 (Gnarra et al.,
1994), in which the levels of HIF, in this case HIF-2α,
are elevated both during normoxia and hypoxia (data
not shown), but in which HIF is a more potent transcrip-
tional activator of an HRE-luc construct during hypoxia
(Figure 4G), in keeping with previous reports (Lando et
al., 2002b). In this cell line, hypoxia also led to en-
hanced Notch ICD-induced Hes-luc and 12XCSL activi-
ties as compared to normoxic conditions (Figures 4Hand 4I). Taken together, these data demonstrate that
the transactivation domain of HIF-1α is required for in-
ducing Notch activity, and they further suggest that not
only the amount, but also the activity status, of HIF-1α
is important for its ability to activate Notch signaling via
Notch ICD.
In the next set of experiments, we investigated the
role of FIH-1 (factor inhibiting HIF-1α) on activation of
the Notch response in hypoxia. FIH-1 reduces the tran-
scriptional activity of HIF-1α by hydroxylating the
asparagine residue 803 of HIF-1α, which, in turn,
blocks HIF coactivator binding (Lando et al., 2002a). As
shown in Figure 5A, Notch 1 ICD-induced activation of
12XCSL-luc was inhibited by transfection of FIH-1 in
P19 cells under either normoxic or hypoxic conditions.
Interestingly, cotransfection of FIH-1 significantly re-
duced activation by Notch 1 ICD also in the absence of
transfected HIF-1a both at hypoxia and normoxia. This
suggests that FIH-1 either affects endogenous HIF ac-
tivity or that FIH-1 plays a more direct role in the regula-
tion of Notch signaling, especially as the HIF-1α levels
are quite low during normoxia (Figure 5A). We also per-
formed protein-protein interaction assays by using bac-
terially expressed GST-tagged FIH-1 and 35S-labeled in
vitro-translated Notch 1 ICD. In these assays, FIH-1
demonstrated an interaction with Notch 1 ICD, albeit at
lower levels than with HIF-1α (Figure 5B).
As the FIH-1 effect may involve CBP/p300 (Lando et
al., 2002a), we tested whether a Notch 1 ICD mutant,
which carries a mutation in the CBP/p300 binding site
and, thus, is incapable of interacting with CBP/p300
(Notch 1 LDE/AAA) (Oswald et al., 2001), responded to
hypoxia. The data show that Notch 1 LDE/AAA is a con-
siderably less potent activator than wild-type Notch 1
ICD, but is still able to activate transcription at hypoxia
(Figure 5C). These results indicate that activation of
Notch downstream genes by hypoxia is independent of
the recruitment of CBP/p300 by Notch 1 ICD, and it will
be of interest to learn whether the hydroxylase activity
of FIH-1 is required for its effect on Notch. Figure 5D
shows that FIH-1 is not a global regulator of gene ex-
pression, as induction from a thyroid hormone-respon-
sive promoter (TRH-luc) was not significantly altered.
HIF-1 Is Recruited to a Notch-Responsive Promoter
in Response to Hypoxia and Activated
Notch Signaling
The interaction between HIF-1α and Notch 1 ICD and
the fact that only the transcriptionally active form of
HIF-1α enhanced Notch signaling (Figure 4E) may sug-
gest that HIF-1α accompanies Notch 1 ICD to a Notch-
responsive promoter. This hypothesis was tested by
Notch 1 ICD- or HIF-1α-specific chromatin immuno-
precipitation assays (ChIP) under various combinations
of hypoxia and Notch activation. Notch activation was
achieved in C2C12 cells after coculture with 293T cells
stably expressing the Serrate 1 (Jagged 1) ligand, and
the cleaved Notch 1 ICD was observed in the C2C12
cells 4 hr after coculture (Figure 6A). When C2C12 cells
were subjected to hypoxia, elevated HIF-1α protein
levels were seen 4 hr after the change from normoxic
to hypoxic conditions (Figure 6A). In order to monitor
chromatin interactions only in the C2C12 cells, not in
Developmental Cell
624Figure 5. FIH-1 Negatively Regulates Notch Signaling in P19 Cells
(A) Coexpression of 12XCSL-luc and Notch 1 ICD with FIH-1 and/
or HIF-1a shows that FIH-1 significantly decreases Notch 1 ICD-
dependent activation of 12XCSL-luc both at normoxia and hypoxia.
(B) FIH-1 interacts with Notch 1 ICD. In vitro-translated, 35S-methio-
nine-labeled Notch 1 ICD or HIF-1α were precipitated by bacterially
expressed GST-tagged FIH-1 by using glutathione-Sepharose
beads.
(C) Coexpression of 12xCSL-luc and Notch 1 ICD or Notch LDE/
AAA during normoxia and hypoxia. Note that the activity of Notch
LDE/AAA is increased during hypoxia.
(D) Coexpression of TRH-luc with TRa and/or FIH-1 in normoxia.
Data are presented as fold activation of luciferase expression rela-
tive to β-galactosidase expression.
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fiation in cortical neural stem cells, myogenic satellite
alues are significant at **p < 0.01, as indicated in the figure. The
ars represent the mean ± SE of two independent experiments per-
ormed in triplicate.he ligand-carrying 293T cells, we took advantage of
he fact that the two cell lines are from different species
mouse versus human) and assigned mouse-specific
rimers for (1) parts of the promoter of the Notch-
esponsive gene Hey-2 (which showed the highest level
f induction by hypoxia in C2C12 cells, and which con-
ains a CSL binding site); and (2) for the promoter from
he PGK1 gene (which is part of the canonical hypoxia
eadout, and which contains HRE sites). Figure 6A
hows that the Hey-2 and PGK1 primers only amplified
equences from mouse (C2C12), not from human
293T), DNA.
The ChIP experiments demonstrated that there were
nly low levels of Notch ICD bound to the Hey-2 pro-
oter in non-Notch-activated C2C12 cells, and that
hese levels were considerably increased when C2C12
ells were cocultured with Serrate 1-expressing 293T
ells, both at normoxia and hypoxia (Figure 6B, second
anel from top). These results are in agreement with
ecently published observations regarding the Hes-1
romoter (Fryer et al., 2004). Interestingly, under the
ombination of hypoxia and ligand-activation of Notch,
inding of HIF-1α to the Hey-2 promoter was observed
Figure 6B, top panel). However, HIF-1α was not de-
ected at the Hey-2 promoter when Notch signaling was
ot activated. Analysis of the PGK1 promoter showed
hat HIF-1α was present at the promoter only in hyp-
xia, and that the interaction was somewhat elevated
hen C2C12 cells were cocultured with Serrate 1-express-
ng cells (Figure 6B, third panel from top). In contrast,
e did not detect any interaction between Notch 1 ICD
nd the PGK1 promoter (Figure 6B, lower panel). Fi-
ally, we wanted to establish whether Notch signaling
ffected transcription mediated by the PGK1 promoter.
e observed an increase in the production of PGK1
RNA in response to hypoxia in the C2C12 cells, and
his increase was slightly reduced in the presence of
he γ-secretase inhibitor L-685,458 (Figure 6C). In con-
lusion, these data show that HIF-1α in response to
ypoxia and Notch signaling is recruited to a Notch-
esponsive promoter.
iscussion
ypoxia controls many important aspects of cellular
ife, and a recently discovered function of hypoxia is to
egulate differentiation in stem/precursor cells in cul-
ure. In CNS precursors, increased proliferation and re-
uced apoptosis are observed in hypoxia (Studer et al.,
000), while hypoxic neural crest stem cells show pro-
oted survival and proliferation coupled with a broader
ifferentiation potential than in normoxia (Morrison et
l., 2000). In this report, we asked whether Notch sig-
aling plays a role in converting the information gener-
ted in hypoxia to a signal for maintenance of an undif-
erentiated cellular state.
We found that hypoxia led to an inhibition of differen-
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625Figure 6. HIF-1α Binds to a Notch-Responsive Promoter in Cells
Grown at Hypoxia and with Activated Notch Signaling
(A) Expression levels of Notch 1 ICD and HIF-1α in C2C12 cells
grown at normoxia or hypoxia after coculture with 293T cells stably
expressing the Serrate 1 ligand (+) or with control 293T cells (−) for
4 hr. Upper panel: Western blot analysis with anti-HIF-1α and anti-
cleaved Notch antibodies. Lower panel: PCR primers amplifying a
part of the Hey-2 or PGK1 promoters are specific for mouse DNA
(C2C12 cells).
(B) ChIP analysis of recruitment of Notch 1 ICD and HIF-1α to the
Hey-2 or PGK1 promoters. On top, a schematic depiction of the
Hey-2 and PGK1 promoters with the amplified promoter regions
and the positions of the CSL binding site (Hey-2) and the HRE sites
(PGK1) denoted. For the ChIP experiments, C2C12 cells were either
cocultured with Serrate 1-expressing 293T cells (+) or with mock
293T cells (−), cultured at normoxia or hypoxia, as indicated. Top
panel: immunoprecipitation for HIF-1α or Notch-1, PCR amplifica-
tion of the Hey-2 promoter. Bottom panel: immunoprecipitation for
HIF-1 or Notch 1 ICD, PCR amplification of the PGK1 promoter.
(C) RT-PCR of PGK1 mRNA in C2C12 cells cultured at normoxia or
hypoxia for 16 hr in the presence or absence of L-685,485.cells, and C2C12 cells, and that pharmacological
blocking of Notch signaling by a γ-secretase inhibitor
alleviated this inhibition and restored differentiation un-
der hypoxic conditions. Similarly, we observed activa-
tion of direct Notch downstream genes by hypoxia, in
agreement with a previous report on upregulation of
Hes-1 mRNA levels in neuroblastoma cells in response
to hypoxia (Jogi et al., 2002). Activation of the Notch
signaling pathway, which includes stabilization of Notch
1 ICD by hypoxia, appears to be mediated via canonical
Notch signaling, i.e., through Notch ICD-CSL interac-
tion, and not to involve direct DNA binding by HIF-1α,
as a synthetic, highly Notch-specific promoter, contain-
ing only CSL binding sites and no perfect HIF-1α re-
sponsive elements, was strongly activated under the
same conditions.
To our knowledge, the link between Notch signaling
and hypoxia represents a novel facet of the hypoxic
response. In the canonical hypoxic response, hypoxia
acts by altering the stability and activity of HIF-1α,
leading to binding of HIF-1α to HRE-containing regula-
tory elements in specific target genes and activation of
such genes, e.g., PAI-1, VEGF, PGK1, transferrin, and
erythropoietin. The difference between the canonical
hypoxic response and the transfer of hypoxic informa-
tion into the Notch signaling pathway resulting in the
activation of bona fide Notch response genes is sche-
matically depicted in Figure 7.
The present data provide strong evidence for a
mechanism of crosstalk between Notch and HIF-1α
signaling pathways, and this mechanism bears an inter-
esting similarity to the recently elucidated mechanism
for crosstalk between Notch and BMP/TGF-β signaling.
In this case, activation of BMP or TGF-β signaling leads
to activation of Notch through interactions between the
intracellular BMP mediator SMAD1 (or SMAD3 for TGF-β
signaling) with Notch ICD (Blokzijl et al., 2003; Dahlqvist
et al., 2003) (reviewed in Kluppel and Wrana, 2005).
SMAD1 interacts with Notch ICD and activates Hes and
Hey transcription. In analogy to the enhancement of
Notch signaling by hypoxia, BMP signaling is capable
of eliciting a response mediated by the 12XCSL-luc
promoter, indicating that there is no need for SMAD
DNA binding, as the 12XCSL promoter is devoid of
SMAD binding sites. Similar to the Notch-hypoxia in-
teraction, BMP also blocks myogenic differentiation in
C2C12 cells in a Notch-dependent manner (Dahlqvist
et al., 2003).
The data presented here indicate that Notch ICD and
HIF-1α are important at the convergence point between
the two signaling mechanisms. The importance of
Notch ICD is underlined by the ability of γ-secretase
inhibitors, which block the S3 cleavage of the Notch
receptor and thus liberation of Notch ICD, to strongly
reduce the hypoxic response on Notch downstream
genes and promoters. Furthermore, the signaling out-
put from an exogenously introduced Notch 1 ICD was
modified by hypoxia, leading to increased activation of
12XCSL-luc and Hes-luc in a Notch 1 ICD-dependent
manner. The importance of HIF-1α in this process re-
ceives support from the observed interaction between
HIF-1α and Notch 1 ICD, the lack of an hypoxia-
induced effect on Notch signaling in fibroblasts devoid
of HIF-1α, and that both the amount and activity status
Developmental Cell
626Figure 7. Schematic Depiction of Crosstalk between Notch and
Hypoxia
In this model, two modes of the hypoxic response are shown: (1)
the canonical hypoxic signaling leading to activation of down-
stream genes such as VEGF, PGK1, and Epo through HIF1α/HIF-1β
binding to HRE elements in the corresponding promoters; and (2)
maintenance of the stem cell state through interaction with the
Notch signaling pathway. In the latter case, HIF-1α and Notch ICD
form a point of convergence between the two signaling mecha-
nisms, leading to stabilization of Notch ICD, recruitment of HIF-1α
to Notch-responsive promoters, and activation of Notch down-
stream genes (Hey and Hes).
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of HIF-1α correlated with the level of Notch activation.
The latter notion is based on the observations that: (1)
transfected HIF-1a elevated the Notch downstream re-
sponse, (2) a transactivation-inactive form of HIF-1α left
the Notch response unchanged, and (3) the response
was augmented in cells lacking VHL. Finally, HIF-1α
was recruited to the Hey-2 promoter in C2C12 cells in
a Notch- and hypoxia-dependent manner. This sug-
gests a mechanism involving an effect of direct tran-
scriptional activation of a Notch-responsive promoter
by HIF-1α, probably as part of a Notch ICD/CSL tran-
scriptional complex (Figure 7). This model is consistent
with the observation that a transcriptionally inactive
form of HIF-1α, which was capable of interacting with
Notch 1 ICD, did not augment the Notch downstream
response. We therefore reason that hypoxia-dependent
stabilization of Notch 1CD is not sufficient for activation
of the Notch response but may require the recruitment
of a form of HIF-1α containing the C-terminal transac-
tivation domain to the Notch ICD/CSL regulatory com-
plex, possibly potentiating the interaction with tran-
scriptional coactivators. This hypothesis is based on
the finding that HIF-1α is recruited to promoters of
Notch downstream genes and the observation that a
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vutated form of Notch ICD, unable to interact with
BP/p300, was transcriptionally active at hypoxia. In
his context, it will be interesting to learn whether HIF-
β also participates in such a regulatory complex.
The link between hypoxia and Notch described here
ay have ramifications for other aspects of hypoxia,
uch as tumor development, in which deregulation of
oth HIF-1α- and Notch-mediated signaling events
ave been implicated (Radtke and Raj, 2003; Weng and
ster, 2004). As many tumors show elevated expression
f HIF-1α, caused by hypoxia inherent to growing tu-
ors and/or genetic loss of VHL (Kondo and Kaelin,
001), it will be interesting to investigate whether the
levated levels of HIF-1α are paralleled by increased
otch signaling, and whether the ensuing Notch induc-
ion contributes to tumor development.
In conclusion, the data presented here demonstrate a
ink between hypoxia and Notch signaling and provide
nsights into how hypoxia maintains the undifferenti-
ted cell state, by using the Notch signaling mecha-
ism. The data also point to an important role for HIF-
α in this process and to the fact that it can interact
ith the Notch intracellular domain to link hypoxic in-
ormation to a Notch response. These data advance our
nderstanding of how Notch crosstalks with other sig-
aling mechanisms and may open up possibilities to
ontrol various aspects of the hypoxic response by ex-
erimentally manipulating Notch signaling.
xperimental Procedures
lasmid Constructs
es-1 luciferase, 12XCSL luciferase, and TRH-luc reporter con-
tructs have previously been described (Jarriault et al., 1995; Kato
t al., 1997; Balkan et al., 1998). The generation of other constructs
sed is described in the Supplemental Data available with this arti-
le online.
ell Culture
ouse myogenic cell line C2C12 and mouse embryonic teratocar-
inoma cell line P19 were grown in Dulbeccos’s modified Eagle’s
edium (DMEM), supplemented with 10% fetal bovine serum
FBS). P19 cells were grown on gelatin-coated dishes. Satellite
ells were cultured as previously described (Dahlqvist et al., 2003).
EF cells were cultured as described in Goda et al. (2003). Cortical
mbryonic stem cells were isolated from rat E14-15 and were cul-
ured in N2 medium. For experimental treatment of cells, see the
upplemental Data.
mmunocytochemistry
ells were fixed in 4% paraformaldehyde, washed with PBS,
locked in blocking solution (3% BSA, 1% Triton X-100 in PBS) for
0 min, and incubated with primary antibody for 1 hr. The antibod-
es used were mouse anti-myosin heavy chain; anti-MHC (MF20,
ybridoma Developmental Studies) diluted 1:15, mouse anti-Tuj-1,
ecognizing β(III)tubulin (Babco) diluted 1:500, rabbit anti-Phospho-
istone 3, recognizing mitotically active cells (Cell Signaling) di-
uted 1:500, or rabbit anti-GFAP (DakoCytomation) diluted 1:500.
fter washing, cells were incubated with secondary antibody, goat
nti-mouse or goat anti-rabbit Alexa 488 (Molecular Probes), for 40
in before being mounted in ProLong mounting medium (Molecu-
ar Probes). Apoptosis was measured by a DNA fragmentation de-
ection kit (Calbiochem). Immunostaining was visualized by using
Nikon Eclipse E800 microscope (20 × magnification) and digitally
maged with Nikon U-III photographic equipment and the Ad-
anced Spot software package (Version 2.2).
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627RNA Extraction and Quantitative RT-PCR
Cells were grown in normoxic or hypoxic (1% O2) conditions for 4
hr. RNA from P19 and C2C12 cells were extracted with Tri Reagent
(Sigma), and RNA from embryonic cortical cells was prepared with
the Qiagen RNeasy Mini Kit according to the manufacturer’s in-
structions. RNA from fibroblast cells was extracted by the Micro-
Midi Total RNA Purification System (Invitrogen) (for details, see the
Supplemental Data).
Transfections
Cells were plated on 6-well dishes. P19 and A-498 cells were trans-
fected with Lipofectamine Plus (Life Technologies, Inc.), and COS-7
cells were transfected with FuGene6 Transfection reagent (Roche)
according to the manufacturers’ instructions (for details, see the
Supplemental Data).
Immunoprecipitation Assays
Protein-protein interaction assays were performed by using in vitro-
translated proteins produced in rabbit reticulocyte lysate (Pro-
mega) according to the manufacturer’s instructions, in the absence
or presence of 35S-methionine (for details, see the Supplemental
Data).
Protein Extraction and Western Blot
P19 cells were lysed in high-salt buffer (50 mM Tris-HCl, 500 mM
NaCl, 1% NP-40, and 20% glycerol) supplemented with 0.5 mM
PMSF and 5 mM 2-mercaptoehanol. COS-7 cells were lysed in lysis
buffer (10 mM Tris-HCl, 300 mM NaCl, 1.5 mM MgCl2, and 0.65%
NP-40). Lysates were cleared by centrifugation for 30 min at 14,000
rpm. Western blot analysis is described in the Supplemental Data.
Pulse-Chase Experiments
P19 cells transfected with pCS2/Notch 1 DE were cultured in DMEM
medium overnight. The next day, culture dishes were pooled and
split. A total of 16 hr after transfection, cells were subjected to an
35S-methionine pulse for 4 hr following a wash with PBS and cul-
ture in DMEM in hypoxic conditions (1% O2) or in normoxia. Lysis
of cells, immunoprecipitation, and gel analysis are described in the
Supplemental Data.
Coculture and Chromatin Immunoprecipitation Experiments
The system for activation of Notch signaling by coculture has been
previously described (Lindsell et al., 1995). C2C12 cells stably ex-
pressing Notch-1 were plated, and the next day either control hu-
man 293T or Serrate-1-expressing 293T cells were seeded at a
density equal to the monolayer of these cells. The coculture was
subjected to either normoxia or hypoxia for 4 hr before isolation of
cell extracts. The chromatin immunoprecipitation procedures are
described in the Supplemental Data.
Supplemental Data
Supplemental Data including data for astrocytic differentiation of
neural progenitors and a more detailed description of the Experi-
mental Procedures are available at http://www.developmentalcell.
com/cgi/content/full/9/5/617/DC1/.
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